N4 Pharma PLC Posting of Annual Report and Notice of AGM (9089E)
04 Marzo 2020 - 1:00AM
UK Regulatory
TIDMN4P
RNS Number : 9089E
N4 Pharma PLC
04 March 2020
04 March 2020
N4 Pharma plc
("N4 Pharma", the "Company" or the "Group")
Posting of Annual Report and Accounts and Notice of AGM
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company
developing Nuvec(R), a novel delivery system for cancer treatments
and vaccines, announces that its Annual Report and Accounts for the
year ended 31 December 2019 and Notice of the Annual General
Meeting will be posted to shareholders later today, and are
available on the Company's website at www.n4pharma.com .
The Company's Annual General Meeting will be held at 1:30 p.m.
on 31 March 2020 at the offices of Shakespeare Martineau LLP, 6th
Floor, 60 Gracechurch Street, London, EC3V 0HR.
Enquiries:
N4 Pharma Plc
Nigel Theobald, CEO Via Scott PR
Allenby Capital Limited Tel: +44(0)203 328 5656
James Reeve/Asha Chotai
Scott PR Tel: +44(0)1477 539 539
Georgia Smith
About N4 Pharma
N4 Pharma is a specialist pharmaceutical company developing a
novel delivery system for cancer and vaccine treatments using its
unique silica nanoparticle delivery system called Nuvec(R).
N4 Pharma's business model is to partner with companies
developing novel antigens for cancer and vaccine treatments to use
Nuvec(R) as the delivery vehicle to get their antigen into cells to
express the protein needed for the required immunity. As these
products progress through pre clinical and clinical programs, N4
Pharma will seek to receive up front payments, milestone payments
and ultimately royalty payments once products reach the market.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NOADXLFBBXLFBBK
(END) Dow Jones Newswires
March 04, 2020 02:00 ET (07:00 GMT)
N4 Pharma (LSE:N4P)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
N4 Pharma (LSE:N4P)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024